Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 7Colorectal Neoplasms 4Prostatic Neoplasms 3Lung Neoplasms 3Breast Neoplasms 3Uterine Cervical Neoplasms 2Pain 2Motor Activity 2Hematopoietic and Lymphatic System Neoplasm 2Carcinoma, Non-Small-Cell Lung 2Breast Carcinoma In Situ 2Squamous Cell Carcinoma of Head and Neck 1Smoking Cessation 1Sedentary Behavior 1Sarcoma 1Recurrence 1Pyloric Stenosis, Hypertrophic 1Pulmonary Disease, Chronic Obstructive 1Polyps 1Patient Satisfaction 1Papillomavirus Infections 1Ovarian Neoplasms 1Neuromuscular Junction Diseases 1Nervous System Diseases 1Neoplasm Metastasis 1Myelodysplastic Syndromes 1Myasthenia Gravis 1Muscle Weakness 1Metastatic Pancreatic Adenocarcinoma 1Malignant Hepatobiliary Neoplasm 1

Interventions

ponatinib 1Telemedicine 1Acceptance and Commitment Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Malignant Hepatobiliary Neoplasm × Telemedicine × Clear all
NCT07124546 2025-08-15

Acceptance and Commitment Therapy (ACT-HBC) for the Improvement of Cancer Distress in Patients With Hepatobiliary Cancers

Mayo Clinic

Phase NA Recruiting
60 enrolled
Gastrointestinal

Malignant Hepatobiliary Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡